RecruitingNCT06472310

Clinical and demOgRaphic Features of Patients With Uncontrolled Severe Asthma in Russia (CORSAR)

An Observational Multicenter Cross-sectional Study of Patients With Uncontrolled Severe Asthma in the Population of the Russian Federation

Sponsor

AstraZeneca

Enrollment

5,000 participants

Start Date

Jun 6, 2024

Study Type

OBSERVATIONAL

Conditions

Severe Asthma

Summary

This study is an observational multicenter cross-sectional study. Planned study population consists of 5 000 adult patients with uncontrolled SA receiving treatment according to standard of care (except biologics). Planned number of study site is 50 outpatient centers with experience of uncontrolled SA treatment in about 50 regions of Russia (in order to describe characteristics of patients with uncontrolled SA in different regions in the most comprehensive way). This non-interventional study does not imply any intervention into a routine clinical practice, and does not provide for any diagnostic and therapeutic procedures other than those used in routine practice.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is collecting real-world clinical and demographic information about patients in Russia who have severe, difficult-to-control asthma. The goal is to better understand this patient population and how they are being managed. **You may be eligible if...** - You are 18 or older with a diagnosis of severe asthma for at least 52 weeks - Your asthma is not well controlled despite being on high-dose inhaled steroids plus at least one additional controller medication for at least 3 months - Your asthma control questionnaire (ACQ-5) score is above 1.5 **You may NOT be eligible if...** - Your asthma is well controlled on current medications - You have been diagnosed with severe asthma for less than 1 year - You have not been on adequate treatment for at least 3 months - You do not provide informed consent Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Locations(37)

Research Site

Astrakhan, Russia

Research Site

Barnaul, Russia

Research Site

Blagoveshchensk, Russia

Research Site

Bryansk, Russia

Research Site

Chelyabinsk, Russia

Research Site

Gatchina, Russia

Research Site

Irkutsk, Russia

Research Site

Izhevsk, Russia

Research Site

Kazan', Russia

Research Site

Kemerovo, Russia

Research Site

Khabarovsk, Russia

Research Site

Krasnodar, Russia

Research Site

Krasnoyarsk, Russia

Research Site

Moscow, Russia

Research Site

Murmansk, Russia

Research Site

Nal'chik, Russia

Research Site

Nizhny Novgorod, Russia

Research Site

Novosibirsk, Russia

Research Site

Omsk, Russia

Research Site

Orenburg, Russia

Research Site

Petrozavodsk, Russia

Research Site

Rostov-on-Don, Russia

Research Site

Ryazan, Russia

Research Site

Saint Petersburg, Russia

Research Site

Samara, Russia

Research Site

Saratov, Russia

Research Site

Stavropol, Russia

Research Site

Tomsk, Russia

Research Site

Ufa, Russia

Research Site

Ulan-Ude, Russia

Research Site

Verkhnyaya Pyshma, Russia

Research Site

Vladimir, Russia

Research Site

Vladivostok, Russia

Research Site

Volgograd, Russia

Research Site

Voronezh, Russia

Research Site

Yakutsk, Russia

Research Site

Yekaterinburg, Russia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06472310

Related Trials

Deployment o the Multidisciplinary Prospective Cohort Imminent

NCT043340311 location

International Severe Asthma Registry: Canadian Cohort

NCT0404558712 locations

Evaluation of Ventilation Defects Downstream of Mucus Plugs in Patients With Severe Asthma

NCT069852251 location

Severe Asthma Network Italy

NCT066252161 location

A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

NCT0727672427 locations